|
Enhanced blood-based colorectal cancer screening with improved performance in detection of early stage disease. |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - Patents related to work |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - Holder of US20210407623A1, US20210214803A1 and US20200131566A1 |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
|
|
Employment - Guardant Health; Kaleida Health (I) |
Stock and Other Ownership Interests - Guardant Health |
Consulting or Advisory Role - CodaCorp |
Patents, Royalties, Other Intellectual Property - I have a couple of patent applications pending review that are not directly related to the material presented as part of this submission. |
|
|
No Relationships to Disclose |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health; Trovagene |
|
|
Employment - Guardant Health |
Leadership - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Research Funding - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
|
|
Employment - Guardant Health |
Leadership - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - Patents filed |